Impact of early abciximab administration on myocardial reperfusion in patients with ST-segment elevation myocardial infarction pretreated with 600 mg of clopidogrel before percutaneous coronary intervention

Journal of Thrombosis and Thrombolysis

Volumn 30, Issue 3, 2010, Pages 347-353

  Dudek, Dariusz ^a   Rakowski, Tomasz ^a   Bartus, Stanislaw ^a   Giszterowicz, Dawid ^b   Dobrowolski, Wojciech ^b   Zmudka, Krzysztof ^c   Zalewski, Jaroslaw ^a   Ochala, Andrzej ^a   Wieja, Pawel ^c   Janus, Bogdan ^d   Dziewierz, Artur ^a   Legutko, Jacek ^a   Bryniarski, Leszek ^a   Dubiel, Jacek S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b District Hospital   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d Catheterization Laboratory   (Poland)

Author keywords

Abciximab; Clopidogrel; Primary percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; EARLY INTERVENTION; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VASCULAR PATENCY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 77957957405     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-010-0461-9     Document Type: Article

References (28)

1. F Van de Werf J Bax A Betriu, et al. 2008 Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European society of cardiology Eur Heart J 29 2909 2945 10.1093/eurheartj/ ehn416 19004841
2. Antman EM, Hand M, Armstrong PW et al. (2008) Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American college of cardiology/American heart association task force on practice guidelines: developed in collaboration with the canadian cardiovascular society endorsed by the American academy of family physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation 117:296-329
3. G De Luca H Suryapranata GW Stone, et al. 2005 Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 1759 1765 10.1001/jama.293.14.1759 15827315
4. G Montalescot D Antoniucci A Kastrati, et al. 2007 Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up Eur Heart J 28 443 449 1:CAS:528:DC%2BD2sXksFWmtr4%3D 10.1093/eurheartj/ehl472 17251257 (Pubitemid 47343560)
5. S Zorman D Zorman M Noc 2002 Effect of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty Am J Cardiol 90 533 536 1:CAS:528:DC%2BD38Xms1ynt7o%3D 10.1016/S0002-9149(02)02530-4 12208418 (Pubitemid 35246047)
6. M Gyöngyösi H Domanovits W Benzer, et al. 2004 ReoPro-BRIDGING study group. Use of abciximab priori to primary angioblasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion-results of the Austrian multi-centre randomized RoePro-BRIDGING Study Eur Heart J 25 2125 2133 10.1016/j.ehj.2004.09.018 15571828 (Pubitemid 39572245)
7. T Rakowski J Zalewski J Legutko, et al. 2007 Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: A randomized study Am Heart J 153 360 365 1:CAS:528:DC%2BD2sXhvVGgsrk%3D 10.1016/j.ahj.2006.12.007 17307412 (Pubitemid 46328765)
8. M Maioli F Bellandi M Leoncini A Toso RP Dabizzi 2007 Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial) J Am Coll Cardiol 49 1517 1524 1:CAS:528:DC%2BD2sXjvFGgt7k%3D 10.1016/j.jacc.2006.12.036 17418289 (Pubitemid 46517954)
9. Herrmann HC, Lu J, Brodie BR et al. for the FINESSE Investigators (2008) Benefit of facilitated PCI in high risk ST elevation MI patients presenting to Non-PCI hospitals. The FINESSE Trial. Presented at TCT 2008 Congress, Washington, USA
10. J Pache A Kastrati J Mehilli, et al. 2002 Clopidogrel therapy in patients undergoing coronary stenting: value of a high-loading-dose regimen Catheter Cardiovasc Interv 55 436 441 10.1002/ccd.10092 11948888 (Pubitemid 34263165)
11. A Kastrati J Mehilli H Schühlen, et al. 2004 Intracoronary stenting and antithrombotic regimen-rapid early action for coronary treatment study investigators. A clinical trial of abciximab in elective percutaneus coronary intervention after pretreatment with clopidogrel N Engl J Med 350 232 238 1:CAS:528:DC%2BD2cXltVSgtw%3D%3D 10.1056/NEJMoa031859 14724302 (Pubitemid 38071801)
12. TIMI Study Group 1985 The thrombolysis in myocardial infarction (TIMI) trial: phase I findings N Engl J Med 312 932 936
13. CM Gibson CP Cannon WL Daley, et al. 1996 TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 879 888 1:STN:280:DyaK287nvFSitQ%3D%3D 8598078
14. AW Van 't Hof A Liem H Suryapranata JC Hoorntje MJ De Boer F Zijlstra 1998 Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade Zwolle myocardial infarction study group Circulation 97 2302 2306 9639373
15. MC Gibson JA de Lemos SA Murphy 2001 Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction a TIMI 14 substudy Circulation 103 2550 2554 1:CAS:528:DC%2BD3MXltVagt7Y%3D 11382722
16. R Schroder R Dissmann T Bruggemann, et al. 1994 Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction J Am Coll Cardiol 24 384 391 1:STN:280:DyaK2czgvVCgsg%3D%3D 10.1016/0735-1097(94)90292-5 8034872
17. J Goedicke M Flather M Noc, et al. 2005 Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies Am Heart J 150 1015.e11 1015.e17 10.1016/j.ahj.2005.07.026 (Pubitemid 41607790)
18. D Dudek Z Siudak M Janzon, et al. 2008 EUROTRANSFER registry investigators. European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab-EUROTRANSFER registry Am Heart J 156 1147 1154 1:CAS:528:DC%2BD1cXhsVWrs7vE 10.1016/j.ahj.2008.08.004 19033011
19. SG Ellis M Tendera MA de Belder 2008 FINESSE investigators. facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2205 2217 1:CAS:528:DC%2BD1cXmt1Gju7o%3D 10.1056/NEJMoa0706816 18499565 (Pubitemid 351724450)
20. G Dangas R Mehran G Guagliumi A Caixeta, et al. 2009 Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial J Am Coll Cardiol 54 1438 1446 1:CAS:528:DC%2BD1MXhtlyqsbnJ 10.1016/j.jacc.2009.06.021 19796737
21. A Kastrati J Mehilli FJ Neumann, et al. 2006 Intracoronary stenting and antithrombotic: regimen rapid early action for coronary treatment 2 (ISAR-REACT 2) trial investigators. abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial JAMA 295 1531 1538 1:CAS:528: DC%2BD28Xjt12isbc%3D 10.1001/jama.295.13.joc60034 16533938
22. AW Van't Hof J Ten Berg T Heestermans, et al. 2008 Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 study group prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial Lancet 372 537 546 10.1016/S0140-6736(08)61235-0 18707985
23. Bonnefoy E (2009) Comparison of the prehospital or cath-lab administration of high dose tirofiban in patients undergoing primary angioplasty: The AGIR-2 study. Presented at American college of cardiology scientific sessions/i2 summit. Orlando, FL, 29 March 2009
24. PJ Vlaar T Svilaas K Damman, et al. 2008 Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review Circulation 118 1828 1836 1:CAS:528: DC%2BD1cXht1Kntb3E 10.1161/CIRCULATIONAHA.107.749531 18852370
25. GW Stone D Cox E Garcia, et al. 2001 Normal flow (TIMI 3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction. Analysis from the primary angioplasty in myocardial infarction trials Circulation 104 636 641 1:STN:280:DC%2BD3Mvktlarsg%3D%3D 10.1161/hc3101.093701 11489767
26. G De Luca N Ernst F Zijlstra, et al. 2004 Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty J Am Coll Cardiol 43 1363 1367 10.1016/j.jacc.2003.11.042 15093868 (Pubitemid 38496339)
27. EC Keeley JA Boura CL Grines 2006 Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials Lancet 367 579 588 1:CAS:528: DC%2BD28XhsFGhs7w%3D 10.1016/S0140-6736(06)68148-8 16488801 (Pubitemid 43247573)
28. G De Luca H Suryapranata JP Ottervanger EM Antman 2004 Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts Circulation 109 1223 1225 10.1161/01.CIR. 0000121424.76486.20 15007008 (Pubitemid 38372780)